Dear OCBN community,
See Save the Date below for the HCA General Meeting, 27-29 June 2022.
Kevin and Inês
Please note, we are resending the Save the Date, as we were notified that some members of our community did not receive it yesterday. If you already received the Save the Date, kindly ignore.
We are pleased to announce that the next Human Cell Atlas General Meeting will be held on 27 - 29 June 2022 in Vienna, Austria. We hope this will be a hybrid meeting with in-person and virtual attendance; however, details will depend on the pandemic situation at the time.
The 2022 HCA General Meeting will convene our community to share updates and insights on new HCA research and initiatives. The meeting theme is “Building draft atlases, integrating across communities, and maximizing impact.” The General Meeting will bring together computational and wet-lab biologists as well as data managers and many other groups from around the world, who will connect, plan and map a path towards the first draft of the atlas. We particularly want to welcome new researchers: Building and connecting the atlases, rendering them broadly useful and accessible, and making progress on the HCA’s goals of positively impacting medicine will take a joint effort.
We hope to meet in-person but capacity will be limited. To maximise audience participation and accessibility all main sessions and breakout sessions will be live-streamed on a dedicated event platform. Sessions will also be made available for on-demand viewing on the event platform, for those not able to attend in real-time.
Safety is our top priority for this meeting. We will be following European Centre for Disease Prevention and Control guidelines as well as the recommendations of the HCA Organizing Committee. Information on COVID-19 safety will be available on the HCA and the meeting websites in the coming weeks.
Please visit our website<https://www.humancellatlas.org/hcameetings/> or email meetings(a)humancellatlas.org<mailto:firstname.lastname@example.org> for more information. We will be in touch with additional details soon.
-- The Wellcome Sanger Institute is operated by Genome Research Limited, a charity registered in England with number 1021457 and a company registered in England with number 2742969, whose registered office is 215 Euston Road, London, NW1 2BE.
I hope everyone remains safe and well. One goal for 2022 for our Oral & Craniofacial Bionetwork is to increase our intra- and inter-group collaboration.
As part of our meta-network to map the inhalation interface (HCA, HuBMAP, CZI), I am looking for collaborators within our OCBN that have access to healthy human tissues from any oral, nasal, pharyngeal, and/or lung site. The goal is to perform optimization and preliminary analysis on FFPE tissues of any of these tissue types from 0-18 year old subjects. There is special interest for those with multiple samples from the same subject as well as those that include male and female tissues of diverse ancestry.
If this is of interest, please email me directly.
Kevin M. Byrd, DDS, Ph.D. byrdk(a)ada.org | he/him/his
Anthony R. Volpe Research Scholar & Manager of Oral & Craniofacial Research
Lab of Oral & Craniofacial Innovation (LOCI); Science & Research Institute
ADA Science & Research Institute, LLC 211 E. Chicago Ave. Chicago, IL 60611 https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ada.org&d=DwIFAw&c=… <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.ada.org_&d=DwIFAw&c… >